Discontinuation report MYLAN-OLANZAPINE ODT
Report ID | 16012 |
Drug Identification Number | 02382717 |
Brand name | MYLAN-OLANZAPINE ODT |
Common or Proper name | OLANZAPINE ODT |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30BL |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-07-12 |
Remaining supply date | 2017-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | There is no saleable inventory remaining. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-07-17 | French | Compare |
v1 | 2017-07-17 | English | Compare |
Showing 1 to 2 of 2